Allogene Therapeutics

Allogene TherapeuticsALLO

Price

$ 2.57

Market Capitalization

$ 536.57 M

Shares Outstading

208.784 M

Change

$ 0.02

Percentage Change

0.78 %

Country

United States 🇺🇸

Industry

Biotechnology

Healthcare

Exchange

NASDAQ Global Select

IPO

2018-10-11

Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candi

Stock Price of Allogene Therapeutics ( ALLO)

Stock Price : $ 2.57

Allogene Therapeutics has Stock Price of $ 2.57 .The current price of Allogene Therapeutics is $2.57 (0.78 %). Stock price history provides a chronological record of a security's past market performance, capturing price fluctuations and trends over time.Stock price will help you analyse historical patterns and market behavior.
Stock Price of Allogene Therapeutics from 2018 to 2024
Year on Year Stock Price of Allogene Therapeutics
Stock Price
YearStock PriceChange %
06-01-2024$ 2.92-62.24%
31-01-2023$ 7.72-32.58%
31-01-2022$ 11.45-67%
29-01-2021$ 34.7059.76%
31-01-2020$ 21.72-28.39%
31-01-2019$ 30.3326.32%
31-10-2018$ 24.01
Market Cap of Magnificent 7

Stock Ticker

Market Cap

Price

Change

Price(30 Days)

Country

$ 3.278 T

$ 441.06

1.94%

$ 8.38

United States🇺🇸

$ 3.267 T

$ 213.07

2.86%

$ 5.92

United States🇺🇸

$ 3.100 T

$ 125.2

3.55%

$ 4.29

United States🇺🇸

$ 2.189 T

$ 179.56

0.77%

$ 1.37

United States🇺🇸

$ 1.945 T

$ 186.89

-0.18%

$ -0.34

United States🇺🇸

$ 1.837 T

$ 7.5513

0.34%

$ 0.03

Saudi Arabia🇸🇦

$ 1.291 T

$ 508.84

0.27%

$ 1.37

United States🇺🇸

NEWSLETTER

MarketStreak weekly Newsletter

Get weekly Stock Market/Crypto News and Jobs updates directly to your inbox.

MarketStreak Research

Research

Latest data-backed business trends, research insights, and industry analyses.

MarketStreak Inc.

TEXAS, USA 🇺🇸

Disclaimer : The content on our website, including hyperlinked sites, associated applications, forums, blogs, and social media accounts, is for general information only and sourced from third-party providers. We offer no warranties regarding the content's accuracy or updatedness. Please note that our content should not be considered financial or legal advice. Always conduct thorough research and consult with a financial advisor before making any decisions. Trading is a high-risk activity that can lead to significant losses, so please seek professional guidance before making any trading decisions. Our content is not meant to be a solicitation or offer.